Evidence map›Paper›PMID 27510741›Full record

Trial reportMedical decision making : an international journal of the Society for Medical Decision Making2017

A Randomized Trial of Expanding Choice Sets to Motivate Advance Directive Completion.

Katherine R Courtright, Vanessa Madden, Nicole B Gabler, Elizabeth Cooney, Jennifer Kim, Nicole Herbst, Lauren Burgoon, Jennifer Whealdon, Laura M Dember, Scott D Halpern

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Medical decision making : an international journal of the Society for Medical Decision Making, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katherine R CourtrightPulmonary, Allergy and Critical Care Division, University of Pennsylvania, Philadelphia, PA (KRC, SDH).
Vanessa MaddenFostering Improvement in End-of-Life Decision Science Program, University of Pennsylvania, Philadelphia, PA (KRC, VM, NBG, EC, JK, LB, SDH).
Nicole B GablerFostering Improvement in End-of-Life Decision Science Program, University of Pennsylvania, Philadelphia, PA (KRC, VM, NBG, EC, JK, LB, SDH).
Elizabeth CooneyFostering Improvement in End-of-Life Decision Science Program, University of Pennsylvania, Philadelphia, PA (KRC, VM, NBG, EC, JK, LB, SDH).
Jennifer KimFostering Improvement in End-of-Life Decision Science Program, University of Pennsylvania, Philadelphia, PA (KRC, VM, NBG, EC, JK, LB, SDH).
Nicole HerbstDepartment of Medicine, Boston University Medical Center, Boston, MA (NH).
Lauren BurgoonFostering Improvement in End-of-Life Decision Science Program, University of Pennsylvania, Philadelphia, PA (KRC, VM, NBG, EC, JK, LB, SDH).
Jennifer WhealdonPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA (JW, SDH).
Laura M DemberRenal-Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA (LMD).
Scott D HalpernPulmonary, Allergy and Critical Care Division, University of Pennsylvania, Philadelphia, PA (KRC, SDH).

Funding

The Penn Roybal Center on Behavioral Economics and Health: Solving for Scale and Impact with Design Thinking, Digital Platforms, and Dynamic AdaptationP30AG034546 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Alison Meredith Buttenheim · 2009 to 2026
$10.6M
A Trial of Expanded Choice Sets in Advance Directives for Hemodialysis PatientsF32DK107109 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI COURTRIGHT, KATHERINE RINALDI · 2015 to 2015
$69k
NIA NIH HHS P30 AG034546NIDDK NIH HHS F32 DK107109
6 · The paper itself

Abstract

backgroundEvidence suggests that advance directives may improve end-of-life care among seriously ill patients, but improving completion rates remains a challenge.

objectiveThis study tested the influence of increasing the number of options for completing an advance directive among seriously ill patients. METHODOLOGY: Outpatients ( N = 316) receiving hemodialysis across 15 dialysis centers in the Philadelphia region between July 2014 and July 2015 were randomized to receive either the option to complete a brief advance directive form or expanded options including a brief, expanded, or comprehensive form. Patients in both groups could decline to complete an advance directive or take their selected version home. The primary outcome was a returned, completed advance directive. Secondary outcomes included whether patients wanted to complete an advance directive, decision satisfaction, quality of life at 3 months, and patient factors associated with advance directive completion.

resultsAlthough offering more advance directive options was not significantly associated with increased rates of completion (13.1% in the standard group v. 12.2% in the expanded group, P = 0.80), it did significantly increase the proportion of patients who wanted to complete an advance directive and took one home (71.9% in standard v. 85.3% in expanded, P = 0.004). There was no difference in satisfaction ( P = 0.65) or change in quality of life between groups ( P = 0.63). A higher baseline quality of life was independently associated with advance directive completion ( P = 0.006). CONCLUSIONS AND RELEVANCE: These results suggest that although an expanded choice set may initially nudge patients toward completing advance directives without restricting choice, increasing actual completion requires additional interventions that overcome downstream barriers.

Indexed as

Advance DirectivesChoice BehaviorAdultAgedAmbulatory Care FacilitiesFemaleHumansMaleMiddle AgedPhiladelphiaRenal Dialysisadvance care planningadvance directivebehavioral economicsend of life

Identifiers

PMID27510741
PMCPMC5303189

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.